Combined therapy against tumors comprising subtituted acryloyl distamycin derivatives and radiotherapy

Details for Australian Patent Application No. 2003219102 (hide)

Owner Nerviano Medical Sciences S.r.l.

Inventors Fowst, Camilla; Geroni, Maria, Cristina, Rosa; Tursi, Jennifer, Margaret

Agent Davies Collison Cave

Pub. Number AU-B-2003219102

PCT Number PCT/EP03/03192

PCT Pub. Number WO2003/082267

Priority 02076240.7 02.04.02 EP

Filing date 17 March 2003

Wipo publication date 13 October 2003

Acceptance publication date 8 May 2008

International Classifications

C07D 207/34 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/4025 (2006.01) - not condensed and containing further heterocyclic rings, e.g. cromakalim

A61K 33/24 (2006.01) Medicinal preparations containing inorganic active ingredients - Heavy metals

A61K 41/00 (2006.01) Medicinal preparations obtained by treating materials with wave energy or particle radiation

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 02076240.7 02.04.02 EP

20 November 2003 Application Open to Public Inspection

  Published as AU-B-2003219102

22 June 2006 Assignment before Grant

  Pharmacia Italia S.p.A. The application has been assigned to Nerviano Medical Sciences S.r.l.

8 May 2008 Application Accepted

  Published as AU-B-2003219102

4 September 2008 Standard Patent Sealed

13 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003219103-Quinoline derivatives and their use as 5-HT6 ligands

2003219101-USE OF THE P17 PROTEIN OF HIV IN ISOLATED FORM FOR THE PREPARATION OF A MEDICAMENT FOR ADMINISTRATION TO HIV SEROPOSITIVE PATIENTS, AS WELL AS PHARMACEUTICAL COMPOSITIONS COMPRISING SAID PROTEIN